medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2016, Number 1

<< Back Next >>

Ann Hepatol 2016; 15 (1)

Hypothermia is better than ischemic preconditioning for preventing early hepatic ischemia/reperfusion in rats

Longo L, Sinigaglia-Fratta LX, Weber GR, Janz-Moreira A, Kretzmann NA, Grezzana-Filho TJM, Possa-Marroni N, Corso CO, Schmidt-Cerski CT, Reverbel-da-Silveira T, Álvares-da-Silva MR, dos-Santos JL

Language: English
References: 50
Page: 110-120
PDF size: 399.24 Kb.


ABSTRACT

Background. Topical hypothermia (TH) and ischemic preconditioning (IPC) are used to decrease I/R injury. The efficacy of isolated or combined use of TH and IPC in the liver regarding inflammation and cytoprotection in early ischemia/reperfusion (I/R) injury needs to be evaluated. Material and methods. Wistar rats underwent 70% liver ischemia for 90 min followed by 120 min of reperfusion. Livers of animals allocated in the sham, normothermic ischemia (NI), IPC, TH, and TH+IPC groups were collected for molecular analyses by ELISA and Western blot, aiming to compare proinflammatory, anti-inflammatory, and antioxidant profiles. Results. Compared with NI, TH presented decreased tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6 and IL-12 concentrations and increased IL-10 levels. TH animals displayed lower inducible nitric oxide synthase (iNOS) and higher endothelial nitric oxide synthase (eNOS) expressions. NAD(P)H-quinone oxidoreductase-1(NQO1) expression was also lower with TH. Isolated IPC and NI were similar regarding all these markers. TH+IPC was associated with decreased IL-12 concentration and reduced iNOS and NQO1 expressions, similarly to isolated TH. Expression of Kelch-like ECH-associated protein (Keap)-1 was increased and expression of nuclear and cytosolic nuclear erythroid 2-related factor 2 (Nrf2) was decreased with TH+IPC vs. NI. Conclusion. TH was the most effective method of protection against early I/R injury. Isolated IPC entailed triggering of second-line antioxidant defense enzymes. Combined TH+IPC seemed to confer no additional advantage over isolated TH in relation to the inflammatory process, but had the advantage of completely avoid second-line antioxidant defense enzymes.


REFERENCES

  1. Knudsen AR, Kannerup AS, Grønbæk H, Dutoit SH, Nyengaard JR, Funch-Jensen P, Mortensen FV. Quantitative histological assessment of hepatic ischemia-reperfusion injuries following ischemic pre- and post-conditioning in the rat liver. J Surg Res 2013; 180: 11-20.

  2. Ildefonso JA, Arias-Díaz J. Pathophysiology of liver ischemia-reperfusion injury. Cir Esp 2010; 87: 202-9.

  3. Dinant S, Veteläinen RL, Florquin S, van Vliet AK, van Gulik TM. IL-10 attenuates hepatic I/R injury and promotes hepatocyte proliferation. J Surg Res 2007; 141: 176-82.

  4. Glantzounis GK, Salacinski HJ, Yang W, Davidson BR, Seifalian AM. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl 2005; 11: 1031-47.

  5. Teoh NC. Hepatic ischemia reperfusion injury: Contemporary perspectives on pathogenic mechanisms and basis for hepatoprotection-The good, bad and deadly. J Gastroenterol Hepatol 2011; 26: 180-7.

  6. Ke B, Shen XD, Zhang Y, Ji H, Gao F, Yue S, Kamo N, et al. KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplants. J Hepatol 2013; 59: 1200-7.

  7. Kireev RA, Cuesta S, Ibarrola C, Bela T, Moreno Gonzalez E, Vara E, Tresguerres JA. Age-related differences in hepatic ischemia/reperfusion: gene activation, liver injury, and protective effect of melatonin. J Surg Res 2012; 178: 922-34.

  8. Mahmoud MF, El Shazly SM, Barakat W. Inhibition of TNF-α protects against hepatic ischemia-reperfusion injury in rats via NF-κβ dependent pathway. Naunyn Schmiedebergs. Arch Pharmacol 2012; 385: 465-71.

  9. Lentsch AB, Yoshidome H, Kato A, Warner RL, Cheadle WG, Ward PA, Edwards MJ. Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice. Hepatology 1999; 30: 1448-53.

  10. Miyake T, Yokoyama Y, Kokuryo T, Mizutani T, Imamura A, Nagino M. Endothelial nitric oxide synthase plays a main role in producing nitric oxide in the superacute phase of hepatic ischemia prior to the upregulation of inducible nitric oxide synthase. J Surg Res 2013; 183: 742-51.

  11. Tsuchihashi S, Kaldas F, Chida N, Sudo Y, Tamura K, Zhai Y, Qiao B, et al. FK330, a novel inducible nitric oxide synthase inhibitor, prevents ischemia and reperfusion injury in rat liver transplantation. Am J Transplant 2006; 6: 2013-22.

  12. Hines IN, Harada H, Flores S, Gao B, McCord JM, Grisham MB. Endothelial nitric oxide synthase protects the postischemic liver: potential interactions with superoxide. Biomed Pharmacother 2005; 59: 183-9.

  13. Shokeir AA, Hussein AM, Barakat N, Abdelaziz A, Elgarba M, Awadalla A. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) and Nrf-2-dependent genes by ischaemic pre-conditioning and post-conditioning: new adaptive endogenous protective responses against renal ischaemia/reperfusion injury. Acta Physiol (Oxf) 2013; 210: 342-53.

  14. Kudoh K, Uchinami H, Yoshioka M, Seki E, Yamamoto Y. Nrf2 activation protects the liver from ischemia/reperfusion injury in mice. Ann Surg 2014; 260: 118-27.

  15. Leonard MO, Kieran NE, Howell K, Burne MJ, Varadarajan R, Dhakshinamoorthy S, Porter AG, et al. Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J 2006; 20: 2624-6.

  16. Gang GT, Hwang JH, Kim YH, Noh JR, Kim KS, Jeong JY, Choi DE, et al. Protection of NAD(P)H:quinone oxidoreductase 1 against renal ischemia/reperfusion injury in mice. Free Radic Biol Med 2014; 67: 139-49.

  17. Morales P, Vargas R, Videla LA, Fernández V. Nrf2 activation in the liver of rats subjected to a preconditioning subchronic iron protocol. Food Funct 2014; 5: 243-50.

  18. Qi Q, Bie P. Different roles of hepatic hypothermic ischemia and ischemic preconditioning in chemically induced hepatocarcinogenesis in rats. J Surg Res 2014; 189: 213-21.

  19. Behrends M, Hirose R, Serkova NJ, Coatney JL, Bedolli M, Yardi J, Park YH, et al. Mild hypothermia reduces the inflammatory response and hepatic ischemia/reperfusion injury in rats. Liver Int 2006; 26: 734-41.

  20. Clavien PA, Selzner M, Rüdiger HA, Graf R, Kadry Z, Rousson V, Jochum W. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843-50.

  21. Choi S, Noh J, Hirose R, Ferell L, Bedolli M, Roberts JP, Niemann CU. Mild hypothermia provides significant protection against ischemia/reperfusion injury in livers of obese and lean rats. Ann Surg 2005; 241: 470-6.

  22. Grezzana Filho TeJ, Mendonça TB, Gabiatti G, Rodrigues G, Marroni NA, Treis L, De Rossi SD, et al. Topical hepatic hypothermia plus ischemic preconditioning: analysis of bile flow and ischemic injuries after initial reperfusion in rats. Acta Cir Bras 2011; 26: 194-201.

  23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.

  24. Sadowski HB, Gilman MZ. Cell-free activation of a DNAbinding protein by epidermal growth factor. Nature 1993; 362: 79-83.

  25. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993; 55: 1265-72.

  26. Eipel C, Glanemann M, Nuessler AK, Menger MD, Neuhaus P, Vollmar B. Ischemic preconditioning impairs liver regeneration in extended reduced-size livers. Ann Surg 2005; 241: 477-84.

  27. Khaliulin I, Halestrap AP, Suleiman MS. Temperature preconditioning is optimal at 26 °C and confers additional protection to hypothermic cardioplegic ischemic arrest. Exp Biol Med (Maywood) 2011; 236: 736-45.

  28. Salido EM, Dorfman D, Bordone M, Chianelli M, González Fleitas MF, Rosenstein RE. Global and ocular hypothermic preconditioning protect the rat retina from ischemic damage. PLoS One 2013; 8: 61656.

  29. An J, Camara AK, Rhodes SS, Riess ML, Stowe DF. Warm ischemic preconditioning improves mitochondrial redox balance during and after mild hypothermic ischemia in guinea pig isolated hearts. Am J Physiol Heart Circ Physiol 2005; 288: H2620-H2627.

  30. Kato A, Singh S, McLeish KR, Edwards MJ, Lentsch AB. Mechanisms of hypothermic protection against ischemic liver injury in mice. Am J Physiol Gastrointest Liver Physiol 2002; 282: G608-G616.

  31. Henry SD, Nachber E, Tulipan J, Stone J, Bae C, Reznik L, Kato T, et al. Hypothermic machine preservation reduces molecular markers of ischemia/reperfusion injury in human liver transplantation. Am J Transplant 2012; 12: 2477-86.

  32. Koneru B, Shareef A, Dikdan G, Desai K, Klein KM, Peng B, Wachsberg RH, et al. The ischemic preconditioning paradox in deceased donor liver transplantation-evidence from a prospective randomized single blind clinical trial. Am J Transplant 2007; 7: 2788-96.

  33. Cui LZ, Wang B, Chen LY, Zhou J. The effect of ischemic precondition to IL-6 on rat liver ischemia-reperfusion injury in transplantation. Asian Pac J Trop Med 2013; 6: 395-9.

  34. Matsumoto T, O’Malley K, Efron PA, Burger C, McAuliffe PF, Scumpia PO, Uchida T, et al. Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning. Surgery 2006; 140: 793-802.

  35. Camargo CA, Madden JF, Gao W, Selvan RS, Clavien PA. Interleukin- 6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26: 1513-20.

  36. Myers KJ, Eppihimer MJ, Hall L, Wolitzky B. Interleukin-12-induced adhesion molecule expression in murine liver. Am J Pathol 1998; 152: 457-68.

  37. Serafín A, Roselló-Catafau J, Prats N, Gelpí E, Rodés J, Peralta C. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 2004; 39: 688-98.

  38. Yoshidome H, Kato A, Edwards MJ, Lentsch AB. Interleukin- 10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kap-paB. Hepatology 1999; 30: 203-8.

  39. Peralta C, Fernández L, Panés J, Prats N, Sans M, Piqué JM, Gelpí E, et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001; 33: 100-13.

  40. Theruvath TP, Zhong Z, Currin RT, Ramshesh VK, Lemasters JJ. Endothelial nitric oxide synthase protects transplanted mouse livers against storage/reperfusion injury: Role of vasodilatory and innate immunity pathways. Transplant Proc 2006; 38: 3351-7.

  41. Ge M, Chi X, Zhang A, Luo G, Sun G, Xie H, Hei Z. Intestinal NF-E2-related factor-2 expression and antioxidant activity changes in rats undergoing orthotopic liver autotransplantation. Oncol Lett 2013; 6: 1307-12.

  42. Yamanaka N, Furukawa K, Tanaka T, Tanaka W, Yamanaka J, Imakita M, Okamoto E. Topical cooling-assisted hepatic segmentectomy for cirrhotic liver with hepatocellular carcinoma. J Am Coll Surg 1997; 184: 290-6.

  43. Jalan R, Olde Damink SW, Deutz NE, Davies NA, Garden OJ, Madhavan KK, Hayes PC, et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation 2003; 75: 2034-9.

  44. Siegel D, Gustafson DL, Dehn DL, Han JY, Boonchoong P, Berliner LJ, Ross D. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 2004; 65: 1238-47.

  45. Dinant S, van Veen SQ, Roseboom HJ, van Vliet AK, van Gulik TM. Liver protection by hypothermic perfusion at different temperatures during total vascular exclusion. Liver Int 2006; 26: 486-93.

  46. Nieuwenhuijs VB, de Bruijn MT, Schiesser M, Morphett A, Padbury RT, Barritt GJ. Ischemic preconditioning and intermittent ischemia preserve bile flow in a rat model of ischemia/ reperfusion injury. Dig Dis Sci 2007; 52: 3029-37.

  47. Azoulay D, Lucidi V, Andreani P, Maggi U, Sebagh M, Ichai P, Lemoine A, et al. Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. J Am Coll Surg 2006; 202: 203-11.

  48. Gurusamy KS, Kumar Y, Sharma D, Davidson BR. Ischemic preconditioning for liver transplantation. Cochrane Database Syst Ver 2008; 1: CD006315.

  49. Pasupathy S, Homer-Vanniasinkam S. Ischemic preconditioning protects against ischemia/reperfusion injury: emerging concepts. Eur J Vasc Endovasc Surg 2005; 29: 106-15.

  50. Schiesser M, Wittert A, Nieuwenhuijs VB, Morphett A, Padbury RT, Barritt GJ. Intermittent ischemia but not ischemic preconditioning is effective in restoring bile flow after ischemia reperfusion injury in the livers of aged rats. J Surg Res 2009; 152: 61-8.




2020     |     www.medigraphic.com